Increased levels of glycosylated hemoglobin, microalbuminuria and serum cystatin C predict adverse outcomes in high‑risk pregnancies with gestational diabetes mellitus

Jin,Hongmei

doi:10.3892/etm.2019.8336

Increased levels of glycosylated hemoglobin, microalbuminuria and serum cystatin C predict adverse outcomes in high‑risk pregnancies with gestational diabetes mellitus

Authors:
- Hongmei Jin
View Affiliations

Affiliations: Department of Obstetrics, Qingpu Branch, Zhongshan Hospital Affiliated to Fudan University, Shanghai 201700, P.R. China
Published online on: December 17, 2019 https://doi.org/10.3892/etm.2019.8336
Pages: 1281-1287
Copyright: © Jin . This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In the present study, the predictive value of glycosylated hemoglobin (HbA1c), microalbuminuria (24 h mAlb) and serum cystatin C (Cys‑C) levels on the outcome of pregnancy in patients with gestational diabetes mellitus (GDM) was investigated. Samples of 144 females with GDM and 117 normal pregnant females as controls were selected for retrospective analysis. The following parameters were compared between the two groups: Levels of HbA1c, Cys‑C and 24 h mAlb, maternal pregnancy outcome and adverse pregnancy rate. The predictive value of elevated 24 h mAlb, HbA1c and Cys‑C regarding an adverse pregnancy outcome was then determined. Cys‑C, 24 h mAlb and HbA1c levels in the GDM group were significantly higher than those in the control group (P<0.001). The adverse pregnancy rate in the GDM group was significantly higher than that in the control group (40.97 vs. 16.24%; P<0.001). Logistic regression and receiver operating characteristics (ROC) analyses indicated that, in subjects with GDM, HbA1c, Cys‑C and 24 h mAlb levels were closely associated with adverse pregnancy outcomes (P<0.050) and may be considered as predictors for an adverse pregnancy outcome (risk ratio >1). Linear correlation analyses indicated that HbA1c, Cys‑C and 24 h mAlb were negatively correlated with the neonatal Apgar scores (r=‑0.509, ‑0.954 and ‑0.954, respectively; P<0.001). According to ROC analysis, the combined predictive sensitivity of HbAlc, Cys‑C and 24 h mAlb for adverse pregnancy outcome in patients with GDM was 96.49% and the specificity was 77.19%. The increase in HbAlc, Cys‑C and 24 h mAlb levels is expected to be an effective predictor of adverse pregnancy outcomes in high‑risk pregnant women.

View Figures

View References

1	Spaight C, Gross J, Horsch A and Puder JJ: Gestational diabetes mellitus. Endocr Dev. 31:163–178. 2016. View Article : Google Scholar : PubMed/NCBI
2	Euser AG, Hammes A, Ahrendsen JT, Neshek B, Weitzenkamp DA, Gutierrez J, Koivunen P, Julian CG and Moore LG: Gestational diabetes prevalence at moderate and high altitude. High Alt Med Biol. 19:367–372. 2018. View Article : Google Scholar : PubMed/NCBI
3	Senat MV and Deruelle P: Gestational diabetes mellitus. Gynecol Obstet Fertil. 44:244–247. 2016.(In French). View Article : Google Scholar : PubMed/NCBI
4	Damm P, Houshmand-Oeregaard A, Kelstrup L, Lauenborg J, Mathiesen ER and Clausen TD: Gestational diabetes mellitus and long-term consequences for mother and offspring: A view from Denmark. Diabetologia. 59:1396–1399. 2016. View Article : Google Scholar : PubMed/NCBI
5	Schoenaker DA, Mishra GD, Callaway LK and Soedamah-Muthu SS: The role of energy, nutrients, foods, and dietary patterns in the development of gestational diabetes mellitus: A systematic review of observational studies. Diabetes Care. 39:16–23. 2016. View Article : Google Scholar : PubMed/NCBI
6	Lu M, Xu Y, Lv L and Zhang M: Association between vitamin D status and the risk of gestational diabetes mellitus: A meta-analysis. Arch Gynecol Obstet. 293:959–966. 2016. View Article : Google Scholar : PubMed/NCBI
7	Rudland VL, Hinchcliffe M, Pinner J, Cole S, Mercorella B, Molyneaux L, Constantino M, Yue DK, Ross GP and Wong J: Identifying glucokinase monogenic diabetes in a multiethnic gestational diabetes mellitus cohort: New pregnancy screening criteria and utility of HbA1c. Diabetes Care. 39:50–52. 2016. View Article : Google Scholar : PubMed/NCBI
8	Baack ML, Forred BJ, Larsen TD, Jensen DN, Wachal AL, Khan MA and Vitiello PF: Consequences of a maternal high-fat diet and late gestation diabetes on the developing rat lung. PLoS One. 11:e01608182016. View Article : Google Scholar : PubMed/NCBI
9	Sherwani SI, Khan HA, Ekhzaimy A, Masood A and Sakharkar MK: Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights. 11:95–104. 2016. View Article : Google Scholar : PubMed/NCBI
10	Pottel H, Delanaye P, Schaeffner E, Dubourg L, Eriksen BO, Melsom T, Lamb EJ, Rule AD, Turner ST and Glassock RJ: Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C. Nephrol Dial Transplant. 32:497–507. 2017.PubMed/NCBI
11	Zhu Y and Zhang C: Prevalence of gestational diabetes and risk of progression to type 2 diabetes: A global perspective. Curr Diab Rep. 16:72016. View Article : Google Scholar : PubMed/NCBI
12	Dipalo M, Buonocore R, Gnocchi C, Picanza A, Aloe R and Lippi G: Analytical evaluation of Diazyme procalcitonin (PCT) latex-enhanced immunoturbidimetric assay on Beckman Coulter AU5800. Clin Chem Lab Med. 53:593–597. 2015. View Article : Google Scholar : PubMed/NCBI
13	Ray JG, Medcalf KE and Park AL: Association of newborn Apgar score with maternal admission to the intensive care unit. JAMA Pediatr. 170:88–89. 2016. View Article : Google Scholar : PubMed/NCBI
14	Rani PR and Begum J: Screening and diagnosis of gestational diabetes mellitus, where do we stand. J Clin Diagn Res. 10:QE01–QE04. 2016.PubMed/NCBI
15	Sovio U, Murphy HR and Smith GC: Accelerated fetal growth prior to diagnosis of gestational diabetes mellitus: A prospective cohort study of nulliparous women. Diabetes Care. 39:982–987. 2016. View Article : Google Scholar : PubMed/NCBI
16	Nahum Sacks K, Friger M, Shoham-Vardi I, Abokaf H, Spiegel E, Sergienko R, Landau D and Sheiner E: Prenatal exposure to gestational diabetes mellitus as an independent risk factor for long-term neuropsychiatric morbidity of the offspring. Am J Obstet Gynecol. 215:380.e1–7. 2016. View Article : Google Scholar
17	Muralimanoharan S, Maloyan A and Myatt L: Mitochondrial function and glucose metabolism in the placenta with gestational diabetes mellitus: Role of miR-143. Clin Sci (Lond). 130:931–941. 2016. View Article : Google Scholar : PubMed/NCBI
18	Retnakaran R and Shah BR: Role of type 2 diabetes in determining retinal, renal, and cardiovascular outcomes in women with previous gestational diabetes mellitus. Diabetes Care. 40:101–108. 2017. View Article : Google Scholar : PubMed/NCBI
19	Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, et al: Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 375:1834–1844. 2016. View Article : Google Scholar : PubMed/NCBI
20	Karges B, Kapellen T, Wagner VM, Steigleder-Schweiger C, Karges W, Holl RW and Rosenbauer J; DPV Initiative, : Glycated hemoglobin A1c as a risk factor for severe hypoglycemia in pediatric type 1 diabetes. Pediatr Diabetes. 18:51–58. 2017. View Article : Google Scholar : PubMed/NCBI
21	Faruque LI, Wiebe N, Ehteshami-Afshar A, Liu Y, Dianati-Maleki N, Hemmelgarn BR, Manns BJ and Tonelli M; Alberta Kidney Disease Network, : Effect of telemedicine on glycated hemoglobin in diabetes: A systematic review and meta-analysis of randomized trials. CMAJ. 189:E341–E364. 2017. View Article : Google Scholar : PubMed/NCBI
22	Lau L, Al-Ismaili Z, Harel-Sterling M, Pizzi M, Caldwell JS, Piccioni M, Lands LC, Mottes T, Devarajan P, Goldstein SL, et al: Serum cystatin C for acute kidney injury evaluation in children treated with aminoglycosides. Pediatr Nephrol. 32:163–171. 2017. View Article : Google Scholar : PubMed/NCBI
23	Hughes RC, Moore MP, Gullam JE, Mohamed K and Rowan J: An early pregnancy HbA1c ≥5.9% (41 mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes. Diabetes Care. 37:2953–2959. 2014. View Article : Google Scholar : PubMed/NCBI
24	Qiu X, Qiu Y, Dai Y, et al: A research of correlation between renal damage of patients with gestational diabetes mellitus and level of serum cystatin C. International Journal of Laboratory Medicine. 10:1289–1290. 2014.
25	Chawla R and Malik S: Microalbuminuria detected at mid term as a marker for adverse pregnancy outcome. Int J Health Sci Res. 8:41–52. 2018.
26	Bargnoux AS, Piéroni L, Cristol JP, Kuster N, Delanaye P, Carlier MC, Fellahi S, Boutten A, Lombard C, González-Antuña A, et al: Multicenter evaluation of cystatin C measurement after assay standardization. Clin Chem. 63:833–841. 2017. View Article : Google Scholar : PubMed/NCBI
27	Fitzpatrick KE, Tuffnell D, Kurinczuk JJ and Knight M: Incidence, risk factors, management and outcomes of amniotic-fluid embolism: A population-based cohort and nested case-control study. BJOG. 123:100–109. 2016. View Article : Google Scholar : PubMed/NCBI